Breaking Big Pharma’s AI barrier: Insilico Medicine uncovers novel target, new drug for pulmonary fibrosis in 18 months
For years, artificial intelligence has promised to shave months, if not years, off the total amount of time needed to develop a brand-new drug—and for potentially millions of dollars less, to boot. But by exactly how much has typically been left up to the imagination, though perhaps coming into clearer focus with each occasional breakthrough.